hydroxychloroquine and bromhexine

hydroxychloroquine has been researched along with bromhexine in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	3 (100.00)	2.80

Authors

Authors	Studies
Chan, R; Lipworth, B; Lipworth, S; RuiWen Kuo, C	1
Aguilar-Gaytán, R; Alvarez-Arce, A; Chávez-Heres, T; Franco-Cendejas, R; Granados-Montiel, J; Hazan-Lasri, E; Manzano-León, N; Martínez-Portilla, RJ; Méndez-Maldonado, K; Silva-Bermudez, P	1
Liu, D; Liu, Y; Lu, D; Pang, G; Ren, R; Wang, X	1

Trials

1 trial(s) available for hydroxychloroquine and bromhexine

Article	Year
New prophylaxis regimen for SARS-CoV-2 infection in health professionals with low doses of hydroxychloroquine and bromhexine: a randomised, double-blind placebo clinical trial (ELEVATE Trial). BMJ open, 2021, 08-03, Volume: 11, Issue:8 Topics: Bromhexine; COVID-19 Drug Treatment; Double-Blind Method; Humans; Hydroxychloroquine; Mexico; SARS-CoV-2; Treatment Outcome	2021

Other Studies

2 other study(ies) available for hydroxychloroquine and bromhexine

Article	Year
Weathering the Cytokine Storm in Susceptible Patients with Severe SARS-CoV-2 Infection. The journal of allergy and clinical immunology. In practice, 2020, Volume: 8, Issue:6 Topics: Administration, Inhalation; Adrenal Cortex Hormones; Age Factors; Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azithromycin; Bromhexine; Coronavirus Infections; COVID-19; Cytokines; Expectorants; Humans; Hydroxychloroquine; Hypertension; Inflammation; Interferon beta-1a; Interleukin-1; Interleukin-12; Interleukin-6; Lymphohistiocytosis, Hemophagocytic; Obesity; Pandemics; Pneumonia, Viral; Pulmonary Disease, Chronic Obstructive; Respiratory Distress Syndrome; Risk Factors; Smoking; Tumor Necrosis Factor-alpha	2020
Kinetics of Drug Molecule Interactions with a Newly Developed Nano-Gold-Modified Spike Protein Electrochemical Receptor Sensor. Biosensors, 2022, Oct-17, Volume: 12, Issue:10 Topics: Antiviral Agents; Bromhexine; COVID-19; Gold; Humans; Hydroxychloroquine; Kinetics; Ligands; Metal Nanoparticles; Molecular Docking Simulation; SARS-CoV-2; Spike Glycoprotein, Coronavirus	2022

Article

Year

Weathering the Cytokine Storm in Susceptible Patients with Severe SARS-CoV-2 Infection.

The journal of allergy and clinical immunology. In practice, 2020, Volume: 8, Issue:6

Topics: Administration, Inhalation; Adrenal Cortex Hormones; Age Factors; Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azithromycin; Bromhexine; Coronavirus Infections; COVID-19; Cytokines; Expectorants; Humans; Hydroxychloroquine; Hypertension; Inflammation; Interferon beta-1a; Interleukin-1; Interleukin-12; Interleukin-6; Lymphohistiocytosis, Hemophagocytic; Obesity; Pandemics; Pneumonia, Viral; Pulmonary Disease, Chronic Obstructive; Respiratory Distress Syndrome; Risk Factors; Smoking; Tumor Necrosis Factor-alpha

2020

Kinetics of Drug Molecule Interactions with a Newly Developed Nano-Gold-Modified Spike Protein Electrochemical Receptor Sensor.

Biosensors, 2022, Oct-17, Volume: 12, Issue:10

Topics: Antiviral Agents; Bromhexine; COVID-19; Gold; Humans; Hydroxychloroquine; Kinetics; Ligands; Metal Nanoparticles; Molecular Docking Simulation; SARS-CoV-2; Spike Glycoprotein, Coronavirus

2022